Pharvaris N.V.

NASDAQ: PHVS · Real-Time Price · USD
22.30
-0.69 (-3.00%)
At close: Aug 15, 2025, 3:59 PM
22.30
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Pharvaris Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Apr 30, 2021
Cash & Equivalents
236.5M 280.73M 305.19M 343.57M 368.34M 391.55M 158.36M 179.19M 135.18M 161.84M 197.73M 201.38M 194.77M 209.35M 218.6M 224.32M 238.32M
Short-Term Investments
n/a n/a n/a 202.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
2.64M 2.94M 2.73M 1.61M 842.6K 1.04M 330K 334.3K 394.08K 382.47K 404.15K 331.93K 669.01K 700.08K 632.37K 712.76K n/a
Inventory
n/a n/a n/a n/a 7.32M n/a 8.99M 8.53M 10.86M 4.04M 3.6M 3.99M 4.76M 1.51M 3.38M 4.23M n/a
Other Current Assets
n/a n/a n/a n/a 271.07K 620.82K 859.87K 948.48K 695.72K 582.59K 633.3K 583.89K 441.1K 5.7K 5.71K 5.63K n/a
Total Current Assets
246.18M 289.42M 312.28M 351.11M 376.78M 398.18M 168.54M 189.01M 147.13M 166.85M 202.36M 206.29M 200.65M 211.57M 222.61M 229.26M 243.87M
Property-Plant & Equipment
1.51M 1.48M 654.92K 392.53K 420.96K 455.95K 495.96K 554.38K 580.88K 626.44K 377.95K 352.56K 349.69K 351.35K 360.38K 360.8K 55.51K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
1.88M 1.96M 898.8K 739.15K 817.06K 843.79K 798.61K 737.89K 670.94K 886.24K 617.38K 452.41K 486.33K 523.4K 477.52K 463.38K 159.47K
Total Assets
248.06M 291.37M 313.18M 351.85M 377.6M 399.02M 169.34M 189.74M 147.8M 167.73M 202.98M 206.74M 201.13M 212.09M 223.09M 229.73M 244.03M
Account Payables
4.23M 4.56M 4.2M 2.97M 5.56M 2.91M 3.61M 4.65M 7.41M 5.98M 6.37M 3.68M 2.85M 2.13M 3.37M 2.9M 3.88M
Deferred Revenue
n/a n/a n/a n/a -120.46K 430.28K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
4.72M 7.83M 4.62M 110.61K 528.07K 429.92K n/a 785.4K 352.25K 461.3K 385.05K 2.81M 128.71K -5.3M 1.45M 347.95K 431.21K
Total Current Liabilities
22.18M 22.97M 16.37M 19.03M 18.36M 14.61M 16.11M 15.9M 18.49M 18.22M 17.72M 16.07M 10.12M 6.99M 7.49M 7.31M 8.45M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.76M n/a n/a n/a
Total Long-Term Liabilities
546.38K 639.04K 17.5K 43.75K 70K 43.6K 96.01K 110.31K 158.4K 249.42K 86.53K 102.09K 122.51K 150.75K 171.47K 189.28K 3.88M
Total Liabilities
22.73M 23.61M 16.39M 19.08M 18.43M 14.66M 16.21M 16.01M 18.65M 18.47M 17.81M 16.17M 10.24M 7.14M 7.66M 7.5M 8.45M
Total Debt
740.98K 861.47K 116.94K 140.38K 190.46K 239.1K 291.35K 338.43K 386.52K 436.82K 198.82K 212.87K 224.34K 250.18K 274.35K 285.92K n/a
Common Stock
6.54M 6.53M 6.51M 6.48M 6.46M 6.28M 4.92M 4.9M 4.06M 4.06M 4.05M 4.05M 3.98M 3.98M 3.98M 3.98M 3.97M
Retained Earnings
-448.71M -402.26M -366.75M -324.77M -294.02M -266.14M -232.61M -208.86M -186.85M -164.19M -124.91M -116.24M -103.6M -87.57M -75.08M -65.94M -50.73M
Comprehensive Income
43.08M 39.85M 36.11M 32.01M 29.88M 27.9M 26.19M 24.26M 22.49M 20.21M 17.57M 14.66M 11.76M 9.8M 8.09M 5.75M 4.04M
Shareholders Equity
225.34M 267.76M 296.79M 332.77M 359.17M 384.37M 153.13M 173.73M 129.15M 149.26M 185.17M 190.57M 190.89M 204.95M 215.43M 222.23M 235.58M
Total Investments
n/a n/a n/a 202.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a